Back to search

Article

PTPN14, a modifier of HHT, protects SMAD4 from ubiquitination and turnover to potentiate BMP9 signaling in endothelial cells

2021-09-30

Abstract excerpt

<h4>ABSTRACT</h4> Hereditary Hemorrhagic Telangiectasia (HHT) results from germline loss-of-function mutations of ENG, ACVRL1 , or SMAD4 , encoding TGFβ/BMP signaling components. Telangiectasias occur in most patients, and pulmonary, visceral, or cerebral arteriovenous malformations (AVMs) in 20-50% of these. How HHT mutations cause these clinical manifestations and why some patients suffer more serious sequela...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6ecb99be-5ea5-5c81-86d9-8d43fcb00475
DOI
10.1101/2021.09.29.462397
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
PTPN14, a modifier of HHT, protects SMAD4 from ubiquitination and turnover to potentiate BMP9 signaling in endothelial cellsDOI 10.1101/2021.09.29.462397
Select a neighboring publication to make it the new centre.